VTE Registry: What Can Be Learned from RIETE?
The Registro Informatizado de Enfermedad TromboEmbólica (RIETE Registry) is an ongoing, international, prospective registry of consecutive patients with acute venous thromboembolism (VTE) designed to gather and analyze data on treatment patterns and outcomes in patients with acute VTE. It started in...
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Rambam Health Care Campus
2014-10-01
|
| Series: | Rambam Maimonides Medical Journal |
| Subjects: | |
| Online Access: | http://rmmj.org.il/Pages/ArticleHTM.aspx?manuId=414 |
| _version_ | 1817992494358462464 |
|---|---|
| author | Inna Tzoran Benjamin Brenner Manolis Papadakis Pierpaolo Di Micco Manuel Monreal |
| author_facet | Inna Tzoran Benjamin Brenner Manolis Papadakis Pierpaolo Di Micco Manuel Monreal |
| author_sort | Inna Tzoran |
| collection | DOAJ |
| description | The Registro Informatizado de Enfermedad TromboEmbólica (RIETE Registry) is an ongoing, international, prospective registry of consecutive patients with acute venous thromboembolism (VTE) designed to gather and analyze data on treatment patterns and outcomes in patients with acute VTE. It started in Spain in 2001, and 6 years later the database was translated into English with the aim to expand the Registry to other countries. In contrast to randomized controlled trials, there is no imposed experimental intervention: the management is determined solely by physicians. Thus, it provides data on patients with VTE in a real-world situation with an unselected patient population. Data from RIETE are hypothesis-generating and provide feedback from real-world clinical situations. So far, we learned about the natural history of VTE in patients with relative or absolute contraindications to anticoagulant therapy. We also learned interesting aspects on the natural history of VTE, and we built a number of prognostic scores to identify VTE patients at low, moderate, or high risk for adverse outcome. |
| first_indexed | 2024-04-14T01:27:23Z |
| format | Article |
| id | doaj.art-8fd8bb3874334bee983cbc294f79db3e |
| institution | Directory Open Access Journal |
| issn | 2076-9172 |
| language | English |
| last_indexed | 2024-04-14T01:27:23Z |
| publishDate | 2014-10-01 |
| publisher | Rambam Health Care Campus |
| record_format | Article |
| series | Rambam Maimonides Medical Journal |
| spelling | doaj.art-8fd8bb3874334bee983cbc294f79db3e2022-12-22T02:20:23ZengRambam Health Care CampusRambam Maimonides Medical Journal2076-91722014-10-0154e003710.5041/RMMJ.10171VTE Registry: What Can Be Learned from RIETE?Inna Tzoran0Benjamin Brenner1Manolis Papadakis2Pierpaolo Di Micco3Manuel Monreal4Department of Hematology and Bone Marrow Transplantation, Rambam Health Care Campus, Haifa, IsraelDepartment of Hematology and Bone Marrow Transplantation, Rambam Health Care Campus, Haifa, Israel and Bruce Rappaport Faculty of Medicine, Technion, Israel Institute of Technology, Haifa, IsraelDepartment of Hematology, Hospital Papageorgion, Saloniki, GreeceDepartment of Internal Medicine, Ospedale Buon Consiglio Fatebenefratelli, Naples, ItalyDepartment of Internal Medicine, Hospital Universitari Germans Trias i Pujol, Badalona, SpainThe Registro Informatizado de Enfermedad TromboEmbólica (RIETE Registry) is an ongoing, international, prospective registry of consecutive patients with acute venous thromboembolism (VTE) designed to gather and analyze data on treatment patterns and outcomes in patients with acute VTE. It started in Spain in 2001, and 6 years later the database was translated into English with the aim to expand the Registry to other countries. In contrast to randomized controlled trials, there is no imposed experimental intervention: the management is determined solely by physicians. Thus, it provides data on patients with VTE in a real-world situation with an unselected patient population. Data from RIETE are hypothesis-generating and provide feedback from real-world clinical situations. So far, we learned about the natural history of VTE in patients with relative or absolute contraindications to anticoagulant therapy. We also learned interesting aspects on the natural history of VTE, and we built a number of prognostic scores to identify VTE patients at low, moderate, or high risk for adverse outcome.http://rmmj.org.il/Pages/ArticleHTM.aspx?manuId=414Anticoagulant therapyoutcomeregistryvenous thromboembolism |
| spellingShingle | Inna Tzoran Benjamin Brenner Manolis Papadakis Pierpaolo Di Micco Manuel Monreal VTE Registry: What Can Be Learned from RIETE? Rambam Maimonides Medical Journal Anticoagulant therapy outcome registry venous thromboembolism |
| title | VTE Registry: What Can Be Learned from RIETE? |
| title_full | VTE Registry: What Can Be Learned from RIETE? |
| title_fullStr | VTE Registry: What Can Be Learned from RIETE? |
| title_full_unstemmed | VTE Registry: What Can Be Learned from RIETE? |
| title_short | VTE Registry: What Can Be Learned from RIETE? |
| title_sort | vte registry what can be learned from riete |
| topic | Anticoagulant therapy outcome registry venous thromboembolism |
| url | http://rmmj.org.il/Pages/ArticleHTM.aspx?manuId=414 |
| work_keys_str_mv | AT innatzoran vteregistrywhatcanbelearnedfromriete AT benjaminbrenner vteregistrywhatcanbelearnedfromriete AT manolispapadakis vteregistrywhatcanbelearnedfromriete AT pierpaolodimicco vteregistrywhatcanbelearnedfromriete AT manuelmonreal vteregistrywhatcanbelearnedfromriete |